Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret Chou

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
JBMR Plus|March 12, 2025
Most infants with prenatal osteogenesis imperfecta diagnosis and poor prognosis survive: experience of a quaternary care osteogenesis imperfecta centerRicki S Carroll, Sarah Little, Tina McGreal, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2002
Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxinGuy R Seabrook, Kathy G Sutton, Wolfgang Jarolimek, et al.
Cancers|January 11, 2024
Kinase Insert Domain Receptor Q472H Pathogenic Germline Variant Impacts Melanoma Tumor Growth and Patient Treatment OutcomesMilad Ibrahim, Irineu Illa-Bochaca, Faisal Fa'ak, et al.
The Journal of Allergy and Clinical Immunology|April 14, 2018
Serum from Asian patients with atopic dermatitis is characterized by T<sub>H</sub>2/T<sub>H</sub>22 activation, which is highly correlated with nonlesional skin measuresHuei-Chi Wen, Tali Czarnowicki, Shinji Noda, et al.
The Journal of Allergy and Clinical Immunology|May 28, 2018
Ichthyosis molecular fingerprinting shows profound T<sub>H</sub>17 skewing and a unique barrier genomic signatureKunal Malik, Helen He, Thy Nhat Huynh, et al.
Cell Reports|June 15, 2022
Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1Qu Deng, Ramakrishnan Natesan, Florencia Cidre-Aranaz, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
JBMR Plus|March 12, 2025
Most infants with prenatal osteogenesis imperfecta diagnosis and poor prognosis survive: experience of a quaternary care osteogenesis imperfecta centerRicki S Carroll, Sarah Little, Tina McGreal, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2002
Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxinGuy R Seabrook, Kathy G Sutton, Wolfgang Jarolimek, et al.
Cancers|January 11, 2024
Kinase Insert Domain Receptor Q472H Pathogenic Germline Variant Impacts Melanoma Tumor Growth and Patient Treatment OutcomesMilad Ibrahim, Irineu Illa-Bochaca, Faisal Fa'ak, et al.
The Journal of Allergy and Clinical Immunology|April 14, 2018
Serum from Asian patients with atopic dermatitis is characterized by T<sub>H</sub>2/T<sub>H</sub>22 activation, which is highly correlated with nonlesional skin measuresHuei-Chi Wen, Tali Czarnowicki, Shinji Noda, et al.
The Journal of Allergy and Clinical Immunology|May 28, 2018
Ichthyosis molecular fingerprinting shows profound T<sub>H</sub>17 skewing and a unique barrier genomic signatureKunal Malik, Helen He, Thy Nhat Huynh, et al.
Cell Reports|June 15, 2022
Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1Qu Deng, Ramakrishnan Natesan, Florencia Cidre-Aranaz, et al.
Pageof 2